Investigators have made a major advance in treating people with a rare but devastating disease of blood vessels.
Researchers Identify Possible New Treatment for Severe Vasculitis
Investigators have made a major advance in treating people with anti-neutrophil cytoplasmic antibody-associated vasculitis, a rare but devastating disease of blood vessels. In a six-month study, a new treatment strategy provided the same benefits as the current standard of care used for more than 40 years but required less frequent treatments. Early results also suggest that patients with disease relapses respond better to the new regimen.
The study, which appears online in the New England Journal of Medicine, was led by John Stone, M.D., M.P.H., of Massachusetts General Hospital, Boston, and Ulrich Specks, M.D., of the Mayo Clinic, Rochester, Minnesota.
Media Contacts: Sue McGreevey, 617 724-2764, email@example.com
U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.